Patient involvement in prostate cancer treatment decisions
| ISRCTN | ISRCTN97145188 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN97145188 |
| Protocol serial number | Dutch Cancer Society 2001-2379; NTR63 |
| Sponsor | Dutch Cancer Society (The Netherlands) |
| Funder | Dutch Cancer Society |
- Submission date
- 12/09/2005
- Registration date
- 12/09/2005
- Last edited
- 28/11/2007
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Cancer
Plain English summary of protocol
Not provided at time of registration
Contact information
Scientific
Radboud University Nijmegen MC
MTA 138
PO Box 9101
Nijmegen
6500 HB
Netherlands
| Phone | +31 (0)24 3610592 |
|---|---|
| p.stalmeier@mta.umcn.nl |
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Non randomised controlled trial |
| Secondary study design | Non randomised controlled trial |
| Scientific title | |
| Study objectives | How many and which patients want to choose their own radiation dose? |
| Ethics approval(s) | Ethics committee CWOM number 0012-0284. Ethics approval date 16 March 2001. |
| Health condition(s) or problem(s) studied | Prostate cancer |
| Intervention | Control group is usual care (150 patients). Intervention group is usual care plus decision aid (150 patients). |
| Intervention type | Other |
| Primary outcome measure(s) |
Primary outcome measure is choice acceptance. At the end of the interview, the patient is asked whether he wants to choose one of the two treatment options, or whether he wants to leave the decision to the physician. The response to this question is choice acceptance. Choice acceptance is confirmed by telephone 2 days later. This measure is obtained about 10 days after the first consultation. |
| Key secondary outcome measure(s) |
1. Substitute preferences of physicians |
| Completion date | 31/12/2006 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Not Specified |
| Sex | Male |
| Target sample size at registration | 300 |
| Key inclusion criteria | Patients with prostate cancer referred for radiotherapy with curative intent are eligible. |
| Key exclusion criteria | Labile personality structure, as assessed by the physicians, and lack of understanding of the Dutch language. |
| Date of first enrolment | 01/01/2001 |
| Date of final enrolment | 31/12/2006 |
Locations
Countries of recruitment
- Netherlands
Study participating centre
6500 HB
Netherlands
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | Not provided at time of registration |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | Results | 20/07/2007 | Yes | No |